SPL 4.35% 11.0¢ starpharma holdings limited

Extract taken from recent interview with CEO of Starpharma Does...

  1. 12,725 Posts.
    lightbulb Created with Sketch. 1354
    Extract taken from recent interview with CEO of Starpharma

    Does it surprise you that big pharma hasn't come in and swooped in and bought the business to get, to get a hold of the dendrimer technology?
    Yeah, look, I think it's a good question. If you think about what they will be paying in licence fees, I think that that is a very realistic and potential ultimate outcome. Yeah, look I think...
    I mean if your dendrimer technology's as good as you say it is then AstraZeneca or somebody like that, or Merck should own it.
    Yeah. I think that is a real possibility.
    Has anyone actually nibbled at this point? Or can you tell us that?
    Well, I think if there was any… yeah, I think if there was anything that required disclosure, then obviously that would mean…
    You would disclose it.
    …that we would disclose it
    Of course. Thanks a lot, Jackie. Great to talk to you.
    Okay. Thanks a lot, Alan.
    That was Dr Jackie Fairley the CEO of Starpharma.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Last
11.0¢
Change
-0.005(4.35%)
Mkt cap ! $45.32M
Open High Low Value Volume
11.5¢ 11.5¢ 11.0¢ $10.37K 94.07K

Buyers (Bids)

No. Vol. Price($)
10 233717 11.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.5¢ 135616 8
View Market Depth
Last trade - 14.23pm 31/05/2024 (20 minute delay) ?
Last
11.0¢
  Change
-0.005 ( 4.35 %)
Open High Low Volume
11.3¢ 11.3¢ 11.0¢ 42215
Last updated 14.33pm 31/05/2024 ?
SPL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.